Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Real-world experience of generalized lipodystrophy patients enrolled in the metreliptin early access program

Trial Profile

Real-world experience of generalized lipodystrophy patients enrolled in the metreliptin early access program

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 15 Nov 2018

At a glance

  • Drugs Metreleptin (Primary)
  • Indications Lipodystrophy
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 15 Nov 2018 New trial record
    • 14 Nov 2018 Results(n=28) of the early access program,presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top